Search Within

Sarwish Rafiq

Formats
  1. Meeting Abstract (8)
  2. Journal Article (7)
Groups
  1. Adult Leukemia (15)
  2. Center for Hematologic Malignancies (15)
  3. Department of Medicine (15)
  4. GSK Faculty (15)
  5. Hematologic Malignancies Research (15)
  6. Hematologic Malignancies, Division of (15)

More Groups

People
  1. Renier Brentjens (15)
  2. Terence Purdon (10)
  3. Hollie Pegram (6)
  4. Oladapo Yeku (5)
  5. Dayenne van Leeuwen (4)
  6. David Scheinberg (3)

More People

Years
  1. 2020 (2)
  2. 2019 (1)
  3. 2018 (4)
  4. 2017 (2)
  5. 2016 (3)
  6. 2015 (2)

More Years

Publications
  1. Blood (3)
  2. Molecular Therapy (2)
  3. Cancer Immunology Research (1)
  4. Cancer Research (1)
  5. Cytotherapy (1)
  6. EBioMedicine (1)

More Publications

Publishers
  1. Nature Publishing Group (7)
  2. American Society of Hematology (3)
  3. American Association for Cancer Research (2)
  4. Elsevier Inc. (1)
  5. Elsevier Science Ltd. (1)
  6. Future Medicine (1)

Results (15)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Tumor derived UBR5 promotes ovarian cancer growth and metastasis through inducing immunosuppressive macrophages
    Journal Article

    Song, M.; Yeku, O. O.; Rafiq, S.; Purdon, T.; Dong, X.; Zhu, L.; Zhang, T.; Wang, H.; Yu, Z.; Mai, J.; more...
    Nature Communications (2020)

    Fulltext@MSK | Save
  • Engineering armored TCR-modified T cells to enhance anti-tumor efficacy
    Meeting Abstract

    Drakes, D. J.; Rafiq, S.; Purdon, T.; Brentjens, R.
    Cancer Immunology Research (2020)

    Fulltext@MSK | Save
  • Modeling anti-CD19 CAR T cell therapy in humanized mice with human immunity and autologous leukemia
    Journal Article

    Jin, C. H.; Xia, J.; Rafiq, S.; Huang, X.; Hu, Z.; Zhou, X.; Brentjens, R. J.; Yang, Y. G.
    EBioMedicine (2019)

    Fulltext@MSK | Save
  • CAR T cells secreting an immune checkpoint blockade scFv have enhanced anti-tumor efficacy
    Meeting Abstract

    Rafiq, S.; Yeku, O.; Jackson, H.; Purdon, T.; van Leeuwen, D.; Yan, S.; Wang, P.; Xiang, J.; Liu, C.; Seshan, V.; more...
    Cancer Research (2018)

    Fulltext@MSK | Save
  • Tumors evading CARs—the chase is on
    Journal Article

    Rafiq, S.; Brentjens, R. J.
    Nature Medicine (2018)

    Fulltext@MSK | Save
  • Targeted delivery of a PD-1-blocking scFV by CAR-T cells enhances anti-tumor efficacy in vivo
    Journal Article

    Rafiq, S.; Yeku, O. O.; Jackson, H. J.; Purdon, T. J.; van Leeuwen, D. G.; Drakes, D. J.; Song, M.; Miele, M. M.; Li, Z.; Wang, P.; more...
    Nature Biotechnology (2018)

    Fulltext@MSK | Save
  • CAR T cells secreting an immune checkpoint blockade scFv have enhanced anti-tumor efficacy
    Meeting Abstract

    Rafiq, S.; Yeku, O.; Jackson, H.; Purdon, T.; van Leeuwen, D.; Yan, S.; Wang, P.; Xiang, J.; Liu, C.; Brentjens, R.
    Molecular Therapy (2018)

    Fulltext@MSK | Save
  • Enhancing CAR T cell anti-tumor efficacy through secreted single chain variable fragment (scFv) immune checkpoint blockade
    Meeting Abstract

    Rafiq, S.; Jackson, H. J.; Yeku, O.; Purdon, T. J.; van Leeuwen, D. G.; Curran, K. J.; Ahmed, R. N.; Cullen, G. D.; Yan, S.; Wang, P.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Optimized T-cell receptor-mimic chimeric antigen receptor T cells directed toward the intracellular Wilms Tumor 1 antigen
    Journal Article

    Rafiq, S.; Purdon, T. J.; Daniyan, A. F.; Koneru, M.; Dao, T.; Liu, C.; Scheinberg, D. A.; Brentjens, R. J.
    Leukemia (2017)

    Fulltext@MSK | Save
  • CD33-directed chimeric antigen receptor (CAR) T cells for the treatment of acute myeloid leukemia (AML)
    Meeting Abstract

    Rafiq, S.; Purdon, T. J.; Schultz, L. M.; Brentjens, R. J.
    Blood (2016)

    Fulltext@MSK | Save